FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne
FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne Print this page REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel… Read More »